CXCR2/CXCR2 ligand biological axis impairs alveologenesis during dsRNA-induced lung inflammation in mice
- PMID: 16183824
- DOI: 10.1203/01.PDR.0000181377.78061.3E
CXCR2/CXCR2 ligand biological axis impairs alveologenesis during dsRNA-induced lung inflammation in mice
Abstract
The histologic phenotype of bronchopulmonary dysplasia (BPD) is characterized by decreased alveolization and is preceded by infiltration of activated neutrophils into the lung that can lead to sustained lung injury and potential interruption of normal lung development. Potential pathogens triggering early neutrophil influx include either prenatal or postnatal exposure to bacteria or viruses. Specific mechanisms recruiting neutrophils to the lung and subsequently decreasing alveolization during virus-induced lung inflammation and injury have not been fully elucidated. Because CXC chemokines, such as CXCL1 and CXCL2/3 acting through their putative receptor, CXCR2, are potent neutrophil chemoattractants, the authors investigated their role in dsRNA-induced lung injury and decreased alveolization, in which dsRNA (poly IC) is a well-described synthetic agent mimicking acute viral infection. Intratracheal dsRNA led to significant increases in neutrophil infiltration and lung injury at 72 hours and to decreased alveolization at 5 days after dsRNA exposure in newborn (10 days old) BALB/c mice, when compared with controls treated and not treated with ssRNA (poly C). Expression of CXCL1 and CXCR2 paralleled neutrophil recruitment to the lung and preceded the decrease in alveolization. Inhibition of CXCR2/CXCR2 ligand interaction by pretreating dsRNA-exposed mice with an anti-CXCR2 neutralizing antibody significantly attenuated neutrophil sequestration and lung injury, and preserved normal alveolization. These findings demonstrate that the CXCR2/CXCR2 ligand biologic axis plays an important role during the pathogenesis of dsRNA-induced lung injury and decreased alveolization and may be relevant to the pathogenesis of BPD.
Similar articles
-
CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection.J Inflamm (Lond). 2005 May 28;2(1):4. doi: 10.1186/1476-9255-2-4. J Inflamm (Lond). 2005. PMID: 15921526 Free PMC article.
-
CXCR2 is critical to hyperoxia-induced lung injury.J Immunol. 2004 Mar 15;172(6):3860-8. doi: 10.4049/jimmunol.172.6.3860. J Immunol. 2004. PMID: 15004193
-
CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.Eur J Pharmacol. 2011 Oct 15;668(3):443-9. doi: 10.1016/j.ejphar.2011.03.025. Epub 2011 Mar 31. Eur J Pharmacol. 2011. PMID: 21458445
-
The role of CXCL1/CXCR2 axis in neurological diseases.Int Immunopharmacol. 2023 Jul;120:110330. doi: 10.1016/j.intimp.2023.110330. Epub 2023 May 27. Int Immunopharmacol. 2023. PMID: 37247498 Review.
-
The role of CXCR2/CXCR2 ligands in acute lung injury.Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):299-303. doi: 10.2174/1568010054022178. Curr Drug Targets Inflamm Allergy. 2005. PMID: 16101537 Review.
Cited by
-
A glucocorticoid-receptor agonist ameliorates bleomycin-induced alveolar simplification in newborn rats.Pediatr Res. 2023 May;93(6):1551-1558. doi: 10.1038/s41390-022-02257-8. Epub 2022 Sep 6. Pediatr Res. 2023. PMID: 36068343
-
Neutrophils and viral-induced neurologic disease.Clin Immunol. 2018 Apr;189:52-56. doi: 10.1016/j.clim.2016.05.009. Epub 2016 Jun 8. Clin Immunol. 2018. PMID: 27288312 Free PMC article. Review.
-
Targeting CXCR2 signaling in inflammatory lung diseases: neutrophil-driven inflammation and emerging therapies.Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug;398(8):9583-9607. doi: 10.1007/s00210-025-03970-x. Epub 2025 Mar 6. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40047857 Review.
-
A subset of epithelial cells with CCSP promoter activity participates in alveolar development.Am J Respir Cell Mol Biol. 2011 Jun;44(6):804-12. doi: 10.1165/rcmb.2009-0429OC. Epub 2010 Aug 6. Am J Respir Cell Mol Biol. 2011. PMID: 20693404 Free PMC article.
-
Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia.Front Med (Lausanne). 2015 Dec 21;2:90. doi: 10.3389/fmed.2015.00090. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26734611 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical